Biologically Active Small Molecules

A metabolite produced during GCDH deficiency and used as a biomarker of glutaric acidemia type 1.

A metabolite produced during GCDH deficiency and used as a biomarker of glutaric acidemia type 1.

An endogenous thyroxine metabolite that activates the trace amine-associated receptor 1 at nanomolar concentrations influences thyroid hormone actions including body temperature, heart rate, and cardiac output as well as balances lipid and glucose

An endogenous thyroxine metabolite that activates the trace amine-associated receptor 1 at nanomolar concentrations influences thyroid hormone actions including body temperature, heart rate, and cardiac output as well as balances lipid and glucose

An endogenous thyroxine metabolite that activates the trace amine-associated receptor 1 at nanomolar concentrations influences thyroid hormone actions including body temperature, heart rate, and cardiac output as well as balances lipid and glucose

3-keto Petromyzonol is a synthetic intermediate useful for pharmaceutical synthesis.

3-keto Petromyzonol is a synthetic intermediate useful for pharmaceutical synthesis.

3-keto Petromyzonol is a synthetic intermediate useful for pharmaceutical synthesis.

Limaprost is an analog of PGE1 with structural modifications intended to give it a prolonged half-life and greater potency. Limaprost is an inhibitor of ADP and collagen-induced platelet aggregation and is 10-1,000 times more potent than PGE1 as an

Limaprost is an analog of PGE1 with structural modifications intended to give it a prolonged half-life and greater potency. Limaprost is an inhibitor of ADP and collagen-induced platelet aggregation and is 10-1,000 times more potent than PGE1 as an

Limaprost is an analog of PGE1 with structural modifications intended to give it a prolonged half-life and greater potency. Limaprost is an inhibitor of ADP and collagen-induced platelet aggregation and is 10-1,000 times more potent than PGE1 as an

Limaprost is an analog of PGE1 with structural modifications intended to give it a prolonged half-life and greater potency. Limaprost is an inhibitor of ADP and collagen-induced platelet aggregation and is 10-1,000 times more potent than PGE1 as an